Transcriptional program associated with IFN-α response of renal cell carcinoma

Journal of Interferon and Cytokine Research

Volumn 26, Issue 3, 2006, Pages 156-170

  Banerjee, Debendranath ^a   Chadalavada, Rajendrakumar S V ^a   Bourdon, Veronique ^a   Korkola, James E ^a   Motzer, Robert J ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; BH3 PROTEIN; CYCLIN DEPENDENT KINASE 2; DNA METHYLTRANSFERASE 1; FAS ANTIGEN; FIBROBLAST GROWTH FACTOR 2; FRIZZLED PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEONECTIN; PROTEIN BAK; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN KINASE C ALPHA; PROTEIN NOXA; PROTEIN P53; RECOMBINANT ALPHA2B INTERFERON; SOMATOMEDIN BINDING PROTEIN 3; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR RUNX1; UNCOUPLING PROTEIN 2;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; KIDNEY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

BIOLOGICAL RESPONSE MODIFIERS; CARCINOMA, HEPATOCELLULAR; CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-ALPHA; KINETICS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 33645401291     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.156     Document Type: Article

References (62)

1. Motzer RJ, Bander NH, Nanus DM. Renal cell carcinoma. N. Engl. J. Med. 1996;335:865-875.
2. Pavlovich CP, Schmidt LS. Searching for the hereditary causes of renal cell carcinoma. Nat. Rev. Cancer 2004;4:381-393.
3. Motzer RJ, Rakhit A, Thompson J, Gurney H, Selby P, Figlin R, Negrier S, Ernst S, Siebels M, Ginsberg M, Rittweger K, Hooftman L. Phase II trial of branched peginterferon-α2a (40 kDa) for patients with advanced renal cell carcinoma. Ann. Oncol 2002;11:1799-1805.
4. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu. Rev. Biochem. 1998;67:227-264.
5. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC, Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003;8:237-249.
6. Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC, Rosen ST. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lac of Stal1 expression. Blood 1998;91:570-576.
7. Leaman DW, Chawla-Sarkar M, Jacobs B, Vyas K, Sun Y, Ozdemir A, Yi T, Williams BR, Borden EC. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-β compared with IFN-α2. J. Interferon Cytokine Res. 2003;12:745-756.
8. Zimmer R, Thomas P. Expression profiling and interferon-beta regulation of liver metastases in colorectal cancer cells. Clin. Exp. Metastasis 2002;19:541-550.
9. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon α, β, γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 1998;95:15623-15628.
10. Houldsworth J, Heath SC, Bosl GJ, Studer L, Chaganti RS. Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells. Cell Growth Differ. 2002;13:257-264.
11. Chadalavada RSV, Houldsworth J, Olshen AB, Bosl GJ, Studer L, Chaganti RS. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonial carcinoma cells. Funct. Integr. Genomics 2005;5:59-69.
12. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high-density oligonucleotide array probe level data. Biostatistics 2003;4:249-264.
13. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001;98:5116-5121.
14. Nanus DM, Pfeffer LM, Bander NH, Bahri S, Albino AP. Antiproliferative and antitumor effects of alpha-interferon in renal cell carcinomas: correlation with the expression of a kidney-associated differentiation glycoprotein. Cancer Res. 1990;50:4190-4194.
15. Liebermann DA, Hoffman B. MyD genes in negative growth control. Oncogene 1998;17:3319-3329.
16. Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 2005;30:151-159.
17. Chalaux E, Lopez-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura FA. Zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett. 1999;457:478-482.
18. Storz P, Doppler H, Ferran C, Grey ST, Toker A. Functional dichotomy of A20 in apoptotic and necrotic cell death. Biochem. J. 2005;387:47-55.
19. Sakamoto E, Hato F, Kato T, Sakamoto C, Akahori M, Hino M, Kitagawa S. Type I and type II interferons delay human neutrophil apoptosis via activation of Stat3 and up-regulation of cellular inhibitor of apoptosis 2. J. Leukoc. Biol. 2005;78:301-309.
20. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030-9040.
21. Friedl P, Vischer P, Freyberg MA. The role of thrombospondin-1 in apoptosis. Cell. Mol. Life Sci. 2002;59:1347-1357.
22. Grimberg A, Liu B, Bannerman P, El-Deiry WS, Cohen P. IGFBP-3 mediates p53-induced apoptosis during serum starvation. Int. J. Oncol 2002;2:327-335.
23. Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS, Mok SC. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am. J. Pathol. 2001;159:609-622.
24. Ghosh A, Sarkar SN, Rowe TM, Sen GC. A specific isozyme of 2′-5′ oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. J. Biol. Chem. 2001;276:25447-25455.
25. Wu WS, Xu ZX, Hittelman WN, Salomoni P, Pandolfi PP, Chang KS. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway. J. Biol. Chem. 2003;278:12294-12304.
26. Kawahara K, Oyadomari S, Gotoh T, Kohsaka S, Nakayama H, Mori M. Induction of CHOP and apoptosis by nitric oxide in p53-deficient microglial cells. FEBS Lett. 2001;506:135-139.
27. Costello RT, Mallet F, Barbarat B, Schiano DE, Colella JM, Sainty D, Sweet RW, Truneh A, Olive D. Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity. Leukemia 2003;12:2500-2507.
28. Boehning D, Patterson RL, Snyder SH. Apoptosis and calcium: new roles for cytochrome c and inositol 1,4,5-trisphosphate. Cell Cycle 2004;3:252-254.
29. Mills EM, Xu D, Ferugsson MM, Combs CA, Xu Y, Finkel T. Regulation of cellular oncosis by uncoupling protein 2. J. Biol. Chem. 2002;277:27385-27392.
30. Scaltriti M, Bettuzzi S, Sharrard RM, Caporali A, Caccamo AE, Maitland NJ. Clusterin overexpression in both malignant and non-malignant prostate epithelial cells induces cell cycle arrest and apoptosis. Br. J. Cancer 2004;91:1842-1850.
31. Vasseur S, Hoffmeister A, Garcia-Montero A, Mallo GV, Feil R, Kuhbandner S, Dagorn JC, Iovanna JL. p8-Deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 2002;21:1685-1694.
32. Hollander MC, Poola-Kella S, Fornace AJ Jr. Gadd34 functional domains involved in growth suppression and apoptosis. Oncogene 2003;22:3827-3832.
33. Rober GK, Kagedal K, Ollinger K. Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 2002;161:89-96.
34. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 2005;23:543-548.
35. Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 2004;29:95-102.
36. Wang W, El-Deiry WS. Targeting FOXO kills two birds with one stone. Chem. Biol. 2004;11:16-18.
37. Tanaka T, Akatsuka S, Ozeki M, Shirase T, Hiai H, Toyokuni S. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 2004;23:3980-3989.
38. Kuroda H, Mandai M, Konishi I, Yura Y, Tsuruta Y, Hamid AA, Nanbu K, Matsushita K, Mori T. Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of insulin-like growth factor-1 by hCG. Int. J. Cancer 1998;76:571-578.
39. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002;4:E131-E136.
40. Toi M, Atiqur-Rahman M, Bando H, Chow LW. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol. 2005;6:158-166.
41. Taira T, Maeda J, Onishi T, Kitaura H, Yoshida S, Kato H, Ikeda M, Tamai K, Iguchi-Ariga SM, Ariga H. AMY-1, a novel C-myc binding protein that stimulates transcription activity of C-myc. Genes Cells 1998;3:549-565.
42. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero M, Pintor-Toro JA. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat. Genet. 2002;32:306-311.
43. Fujii M, Hayashi K, Niki M, Chiba N, Meguro K, Endo K, Kameoka J, Ito S, Abe K, Watanabe T, Satake M. Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis. Oncogene 1998;17:1813-1820.
44. Kwaan HC, Wang J, Svoboda K, Declerck PJ. Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. Br. J. Cancer 2000;82:1702-1708.
45. Yokochi T, Robertson KD. Doxorubicin inhibits DNMT1, resulting in conditional apoptosis. Mol. Pharmacol. 2004;66:1415-1420.
46. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, Dennewitz MB, Shin B, Datta A, Raychaudhur P, Costa RH. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 2004;18:830-850.
47. Li Y, Zhang H, Xie M, Hu M, Ge S, Yang D, Wan Y, Yan B. Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem. J. 2002;367:413-422.
48. Porta C, Hadj-Slimane R, Nejmeddine M, Pampin M, Tovey MG, Espert L, Alvarez S, Chelbi-Alix MK. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 2005;24:605-615.
49. Qian N, Frank D, O'Keefe D, Dao D, Zhao L, Yuan L, Wang Q, Keating M, Walsh C, Tycko B. The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum. Mol. Genet. 1997;6:2021-2029.
50. Unoki M, Nakamura Y. EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK. Oncogene 2003;22:2172-2185.
51. Martins GA, Vieira LQ, Cunha FQ, Suva JS. Gamma Interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect. Immun. 1999;67:3864-3871.
52. Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L. Rodriguez-Peralto JL, Fernandez-Herrera J, Hernandez A, Fraga J, Dominguez O, Herrero J, Alonso MA, Dopazo J, Prisi MA. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am. J. Pathol 2002;161:1825-1837.
53. Nanus DM, Schmitz-Drager BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Cardo C, Albino AP, Reuter VE. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. Natl. Cancer Inst. 1993;85:1597-1599.
54. Peluso JJ. Basic fibroblast growth factor (bFGF) regulation of the plasma membrane calcium ATPase (PMCA) as part of an anti-apoptotic mechanism of action. Biochem. Pharmacol. 2003;66:1363-1369.
55. Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999;18:3017-3033.
56. Gonzalez S, Perez-Perez MM, Hernando E, Serrano M, Cordon-Cardo C. p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition. Cancer Res. 2005;65:2186-2192.
57. Shav-Tal Y, Zipori D. The role of activin a in regulation of hemopoiesis. Stem Cells 2002;20:493-500.
58. Hofmann R, Lehmer A, Buresch M, Hartung R, Ulm K. Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma. Cancer 1996;78:487-492.
59. Hotakainen K, Ljungberg B, Haglund C, Nordling S, Paju A, Stenman UH. Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum. Int. J. Cancer 2003;104:631-635.
60. Suzuki K, Morita T, Hashimoto S, Tokue A. Thymidine phosphorylase/ platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma. Urol. Res. 2001;29:7-12.
61. Mizutani Y, Wada H, Yoshida O, Fukushima M, Nonomura M, Nakao M, Miki T. Significance of thymidylate synthase activity in renal cell carcinoma. Clin. Cancer Res. 2003;9:1453-1460.
62. Zimmermann U, Woenckhaus C, Pietschmann S, Junker H, Maile S, Schultz K, Protzel C, Giebel J. Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch. 2004;445:368-374.